Compare Goodyear Tire & Rubber Co (GT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Goodyear Tire & Rubber Co vs Recursion Pharmaceuticals Inc — how do they compare? Goodyear Tire & Rubber Co trades at $6.12 (market cap $1.75B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Goodyear Tire & Rubber Co and Recursion Pharmaceuticals Inc are close in size by market cap. Which is the better fit depends on your goals.
| GT | RXRX | |
|---|---|---|
Market Cap | $1.75B | $1.81B |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $6.79 |
52-Week Low | $5.58 | $2.84 |
Enterprise Value | $9.11B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
